Company intelligence / Profile preview

seca

Hamburg, Hamburg, Germanyseca.com ↗

Ownership: Private
Development stage: Other

Overview

seca is the global leader in medical measuring and weighing solutions, providing advanced body composition analyzers and digital health tools that enable healthcare providers to move beyond weight/BMI toward comprehensive obesity care. Their latest product, mBCA Alpha, uses validated bioelectrical impedance analysis to deliver rapid body composition results integrated with cloud-based reporting and patient apps. The company’s solutions are trusted worldwide in obesity medicine, bariatrics, metabolic health, and general clinical practice.

Therapeutic areas: Metabolic DisordersEndocrinologyCardiovascular
Modalities: DeviceSoftware (for clinical workflow integration and analytics)
Industry: Physiological Monitoring

Beyond the preview

Go deeper on seca.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on seca.

Explore the full profile